Editorial Team
—————————————— Editor-in-Chief ——————————————
Affiliation: Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Australia
Interests: Functional clay nanoparticles; Drug delivery; Combination cancer therapy; Cancer immunotherapy; Nano-biosensors
Biography: Prof. Xu is a senior group leader at the Australian Institute for Bioengineering and Nanotechnology, The University of Queensland. His research focuses on control preparation of layered double hydroxide nanomaterials, calcium phosphate nanoparticles, nanoemulsions, quantum dots, chemosensros and nanosensors, and their applications in biomedicine and agriculture. He has published over 330 peer-reviewed journal papers, conference papers and book chapters. His research has led to many high quality papers published in Nature Plants, Adv Mater, Nano Letters, JACS, Angew Chim Int Ed, Adv Funct Mater, Biomaterials, J Control Release, Chem Mater, Small, Nanoscale, ACS Appl Mater Interface and nanomedicine. Specifically, his publications on layered double hydroxide materials from 2008-2018 rank him in the top #6 among more than 1000 scientists in this research field in terms of the journal paper count. His papers have been cited over 19,395 times with the H-index of 75. He works as Editorial Board Member for six journals, such as Journal of Nanotechnology and Smart Materials, Frontiers in Inorganic Chemistry, Biointerface Research in Applied, and Current Pharmaceutical Design. He also served as reviewers of over 20 journals, including JACS, Biomaterials, Small, Nature Commun, Nanoscale, Adv Functional Mater, Chem Mater, ACS Appl Mater Interface, J Mater Chem B, J Phys Chem B and C.
—————————————Executive Associate Editors ——————————————
Lei Huang 
view >>
Affiliation: Department of Molecular Cell and Cancer Biology, University of Massachusetts Medical School, US
Interests: Cancer Therapy; Cell Metabolism; Gene Editing; Signaling Pathway; Obesity and Diabetes
Biography: Dr. Huang focuses on the molecular mechanism of obesity (BAT development and iWAT browning), diabetes (selective and total insulin resistance) and cancer therapy. He has published more than 30 papers (first author or corresponding author) in scientific journals including Nature Communications (3 papers); Advanced Science; Cell Reports; Journal of Biological Chemistry; Developmental Cell. He was awarded Top 1% global reviewer in the field of Clinical Medicine, Molecular Biology & Genetics and Cross-field by Web of Science Group and Publons in 2018 and 2019; He served as a grant reviewer for Nature Science Foundation of China (life science and medicine); He also served as a reviewer for 50 SCI journals and a scientific editor for 10 SCI journals.
————————————— Associate Editors ——————————————
Seifedine Kadry view ≫
Affiliation: Noroff University College, Norway
Interests: Data Science, Medical Image Analysis
Biography: Dr Seifedine Kadry has a bachelor’s degree in 1999 from Lebanese University, MS degree in 2002 from Reims University (France) and EPFL (Lausanne), PhD in 2007 from Blaise Pascal University (France), HDR degree in 2017 from Rouen University. He is a Professor of Data Science at Noroff University College, Norway. At present his research focuses on Data Science, education using technology, system prognostics, stochastic systems, and applied mathematics. He is an ABET program evaluator for computing, and ABET program evaluator for Engineering Tech. He is a Fellow of IET, Fellow of IETE, and Fellow of IACSIT. He is a distinguish speaker of IEEE Computer Society.
Sebastian Oltean view ≫
Affiliation: Experimental Medicine and Therapeutics Department of Clinical & Biomedical Sciences University of Exeter Medical School, USA
Interests: Diabetic nephropathy；Prostate cancer；Angiogenesis；Epithelial-mesenchymal transitions and fibrosis；Alternative splicing regulation
Biography: The main goals of his research projects are to understand disease pathogenesis and to find novel therapeutic targets. Dr. Sebastian won Young Investigator Award for outstanding research by a postdoctoral fellow, and British Microcirculation Society poster prize. He published research articles on Mol Ther Methods Clin Dev, Molecular Oncology, Oncogenesis, British Journal of Cancer, Am J Respir Crit Care Med and Cancer Cell. He also served as a reviewer and Editorial Board Member for many journals such as Clinical and Translational Discovery, Highlights of Molecular Science, Frontiers in Genetics, World Journal of Clinical Oncology, Frontiers in Oncology, Chemical Communications, Cancer Immunology, Clinical Cancer Research, etc.
Shan Jiang view ≫
Affiliation: Hangzhou Institute of Technology, Xidian University
Interests: Flexible electronics, Bioelectronics, Metamaterials, Metasurfaces
Biography: Dr. Jiang is currently a PI and an associate professor at Hangzhou Institute of Technology, Xidian University, Xi’an, China. He earned his Ph.D. in Solid Mechanics from Huazhong University of Science and Technology (HUST), Wuhan, China, in 2018. He then worked as a Postdoctoral Fellow in HUST during 2019-2022. His research interests include design, manufacturing, and application of flexible electronics, bioelectronics, metamaterials, and metasurfaces. He proposed the concepts of ‘flexible metamaterial electronics’ and ‘electronic armor’ in research community for the first time. By now, he has published 1 monograph and more than 20 papers (first author or corresponding author) including some papers in high-profile journals such as Advanced Materials (2 papers), Innovation (2 papers), Materials & Design, Carbon, and Composite Structures. His research proposals have achieved funding support from the National Natural Science Foundation of China, the National Key Research and Development Project, the Fundamental Research Funds for the Central Universities, etc. He served as a grant reviewer for National Natural Science Foundation of China (Engineering and material science). He also served as a guest editor of Rare Metals and a reviewer for 20 SCI journals.
Fu Wang view ≫
Affiliation: Xi'an Jiaotong University, China
Interests: Cancer imaging; Targeting therapy; Cancer theranostics; Nanomedicine; Gene regulation
Biography: Prof. Wang is currently a Professor at Xi’an Jiaotong University, and also a Fujian Provincial “Minjiang Scholar” Chair Professor. His main research area is biomedical imaging and cancer theranostics. In recent years, Prof. Wang has published more than 40 SCI papers in international mainstream journals such as PNAS, Nature Protocols, Nucleic Acids Research, Oncogene, etc. He also authorized more than 10 Chinese invention patents, and won the first prize of Shaanxi Provincial Higher Education Science and Technology Award, the third prize of the Shaanxi Provincial Science and Technology Award as the first contributor.
Wei Zhao view >>
Affiliation: Chengdu Medical College, China
Interests: Cancer drug resistance; Tumor microenvironment; Cancer stem cell
Biography: Dr. Wei Zhao is currently an associate professor at the school of Laboratory Medicine at the Chengdu Medical College. His active research fields include (1) reversal of multidrug resistance induced by reprogrammed metabolism, (2) new drug research and development for treatment of cancer patients, (3) primary cancer tissue culture and test of drug sensitivity for personalized chemotherapy. He has published over 30 papers in related fields, including Oncogene, JBC, Front. Immunol and Mol. Cancer.
Hang Song view>>
Affiliation: Anhui University of Chinese Medicine, China
Interests: Genetics and epigenetics; Precision medicine; Molecular mechanism; Digestive system cancers; Intervention and treatment
Biography: Dr. Song focuses on epigenetic mechanism underlying Western medicine and traditional Chinese medicine therapies for patients with digestive system cancers. He has published more than 30 papers in scientific journal including Signal Transduction and Targeted Therapy (IF=38.104), Clinical and Translational Medicine (IF=11.492), Pharmacological Research (IF=10.334) etc. He has leaded and contributed numerous public funded research and industry projects including National Natural Science Foundation of China and China Postdoctoral Science Foundation. He was accredited Youth Wan Jiang Scholar of Anhui Province and Excellent Young Scholars Project of Natural Science Foundation of Anhui Province in China.
Lingxiao Zhang view>>
Affiliation: Zhejiang University City College, China
Interests: Biomaterials; Cancer Immunotherapy; Neurodegenerative disease imaging and therapy; Drug Delivery
Biography: Dr. Lingxiao Zhang focuses on the development of two-dimensional clay materials-based nanobiotechnological drugs and nanovaccines for the diagnosis and therapy of malignant tumors and neurodegenerative diseases. Up till now, he has published 24 high-quality articles in well-known journals such as Advanced Materials, ACS Nano, Advanced Drug Delivery Reviews, Nano Today, Biomaterials, Nano Research, ACS Applied Materials & Interfaces and Journal of Nanobiotechnology with an average impact factor of 15.272. He was also awarded with numerous honors include the TOP100 Excellent Doctoral Dissertation of the Chinese Academy of Sciences, Dean's Excellence Award of the Chinese Academy of Sciences and European Commission Horizon Seal of Excellence. As project leaders, he has undertaken a number of projects such as Chinese National Natural Science Foundation Project and HORIZON TMA MSCA Postdoctoral Fellowships with a total funding of CNY 4 million. He also serves as a Guest Editor of Journal of Nanobiotechnology, and journal reviewer for Coordination Chemistry Reviews, Acta Biomaterialia and Journal of Nanobiotechnology.
Mingyang Liu view >>
Affiliation: Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China
Interests: Pancreatic cancer microenvironment, Tumor migration and metastasis, Tumor chemoresistance
Biography: Prof. Liu focuses on pancreatic cancer microenvironment and chemoresistance. In recent years, Prof. Liu has published more than 20 SCI papers in high impact journals including Gastroenterology (5), Clinical Cancer Research (7), Cancer Research, Drug Resistance Updates, EbioMedicine etc and published one editorial paper in Gastroenterology. Prof. Liu received Outstanding Young Investigator Award from American Pancreatic Association (APA) and International Associate for Pancreatology (IAP) for several times. Prof. Liu is the PI of General Program supported by the National Natural Science Foundation of China. Prof. Liu is the 2nd Council of Pancreatic Association-Chinese International Exchange and Promotion Association for Medical and Health Care.
THAKUR Abhimanyu view>>
Affiliation: Pritzker School of Molecular Engineering, Ben May Department for Cancer Research, University of Chicago，Chicago, IL, USA
Interests: Biomedical Science; Cancer Research; Molecular Engineering
Biography: Abhimanyu Thakur obtained his B. Pharm. (2009-2013) from B.C.D.A. College of Pharmacy & Technology (affiliated to West Bengal University of Technology, Kolkata, India), and M. Pharm. (2013-2015) from the Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology (BIT) Mesra, Ranchi, India. After working in Quintiles Research Ltd. (now IQVIA) as Pharmacovigilance Safety Associate, he joined Dr. Youngjin Lee's lab at Department of Biomedical Sciences, City University of Hong Kong (CityU) in September, 2015. He obtained Ph.D. in Biomedical Sciences (Glioma Biology) in Aug 2019. His Ph.D. work is about glioma (brain cancer) biology. Currently, he is working as a Post-doctoral Fellow. Currently, he has published over 30 research papers in prestigious journals, including Bioactive Materials (IF=14.593), Science Advances (IF=14.139), Protein and Cell (IF=14.87), Chemical Engineering Journal (IF=13.237), Biosensors and Bioelectronics (IF=10.619), etc.
Zhijie Xu view>>
Affiliation: Xiangya Hospital, Central South University, Hunan Province, China.
Interests: Cancer research; Molecular biology; Cell death; Post-translational modification
Biography: Dr. Xu specializes in Pathology and Pathophysiology in Oncology. He mainly focuses on the cancer pathogenesis, with a goal of translating mechanistic insights gained for new therapeutic modalities. He published over 110 research papers in prestigious journals, including Mol Cancer (IF=27.401), Nucleic Acids Res (IF=16.971), J Hematol Oncol (IF=17.388), J Thorac Oncol (IF=13.357), Clin Transl Med (IF=11.492), Acta Pharm Sin B (IF=11.413), etc. Presently, Dr. Xu serves as the Associate Editor for BMC Pulm Med, Frontiers in Pharmacology, etc.
——————————————— Editorial Board Members ——————————————
Lufeng Zheng view>>
Affiliation: China Pharmaceutical University
Interests: Breast tumor; Cancer stem cells; Pharmacology
Biography: Dr. Lufeng Zheng is a collaborative, studious medical oncologist with a strong molecular-biology background, passionate about cancer metastasis, stemness, and drug resistance, and translating research into cancer prevention and control. He has published more than 45 papers in scientific journal including J Hematol Oncol, EBioMedicine, Mol Ther Nucleic Acids, J Med Chem, Genes Dis, Stem Cell Res Ther, Front Immunol, Mol Pharm, FASEB J, etc. He led and contributed to numerous public funded research projects, including the National Natural Science Foundation Project, the Special Postdoctoral Funding Scheme, etc.
Bingjie Zhang view ≫
Affiliation: New York Genome Center, US
Interests: Epigenetics; Single-cell omics; Cancer; Gene regulation
Biography: Dr. Bingjie Zhang is currently a postdoctoral fellow in the laboratory of Rahul Satija at the New York Genome Center, where she focuses mainly on developing cutting-edge multimodal single cell technologies to understand epigenetic regulation during cell lineage commitment. As a graduate student under the guidance of Dr. Wei Xie at Tsinghua University, she was dedicated to exploring histone modification reprogramming during early embryo development. She has published several papers as first-author in high impact scientific journals including Nature, Nature Biotechnology, Molecular Cell and Science Advances.
Chunjie Jiang view ≫
Affiliation: MD Anderson Cancer Center, US
Interests: Non-coding RNA; Transcriptional regulation; Cancer Biology; Metabolism
Biography: Dr. Chunjie Jiang focuses on the transcriptional regulation in cancer biology and metabolism. He has published 29 papers in scientific journals including Cell, Science, Nature Neuroscience, and PNAS, including more than 10 first/co-first author papers published on Cell Metabolism, Cell Stem Cell and Genes & Development. He also serves as reviewer for more than 30 journals including Frontiers in series, BMC series, The Innovation, Briefings in Bioinformatics, and Journal for ImmunoTherapy of Cancer.
Murtaza Hasan view ≫
Affiliation: School of Chemistry and Chemical Engineering, Zhongkai Agriculture University of Engineering, Guangzhou, China
Interests: Biomedical sciences; Nanobiotechnology; Drug delivery; Cancer biology; Metabolomics
Biography: Dr. Murtaza Hasan focuses on nano-biotechnology, green synthesis and cancer detection. He has won NRPU Research project with funding 2.7 million. Until now, he has published more than 110 research articles in scientific journals including Nano Research, Nano Convergence, Environmental Research, Acs Sensors, Journal of Alloys and Compounds, Materials Today Communication, Antioxidants, Journal of Materials Research and Technology, etc. And he works as guest editor for Frontier in Chemistry and Applied Science. He also served as reviewers for nearly 40 articles in prestigious journals, including International Journal of Molecular Science, Molecule, Recent Progress in Material, International Journal of Molecular Science, etc.
Haineng Xu view ≫
Affiliation: University of Pennsylvania Perelman School of Medicine, US
Interests: Cancer; DNA damage; Targeting therapy; Cancer gene therapy; Cancer microenvironment; Cancer stem cell
Biography: Dr. Haineng Xu focuses on discovering and developing targeting therapy for ovarian cancers by exploiting genetic vulnerability. He has published over 30 papers in scientific journals including Nature Communications, Cell Reports Medicine, Cancer Research, Molecular Cancer, Cell Death Disease. He served as a reviewer for more than 50 journals including Molecular Cancer, Cancer Letters. He is or has been on the editorial board/guest editor/review editor for BMC Cancer, Open Medicine, Oncology Letters, Frontiers in Oncology, Frontiers in Pharmacology, Frontier in Immunology.
Kui Zhang view ≫
Affiliation: Pritzker School of Molecular Engineering, University of Chicago, US
Interests: Cancer; Cancer Stem Cell; Metastasis; Drug-delivery; Single-cell multimodal omics
Biography: Dr. Kui Zhang focuses on the initiation, metastasis, and treatment of the malignant cancers. Until now, his high-level research projects have received fundings from National Natural Science Foundation of China and the Chinese Postdoctoral Science Foundations. Also, he has published more than 40 papers in scientific journals including Nature communications, Protein & Cell, Seminars in Cancer Biology, Cell Death & Disease, and Cancer Letters. He also served as the invited reviewers or guest editor for more than 10 journals, including Frontiers in series, Cancers, Cells, Genes & Diseases, Journal of Cell Communication and Signaling, and Toxins.
Ricardo Izurieta view ≫
Affiliation: University of South Florida, USA
Interests: Carcers of infectious diseases ethiology
Biography: Ricardo Izurieta, MD, Dr.PH, MPH is Professor and Director of Global Communicable Diseases at College of Public Health and Director of the Public Health Scholar Concentration at Morsani College of Medicine, University of South Florida in Tampa. In 2003, Dr. Izurieta was elected Vice President of the Gorgas Memorial Institute of Tropical and Preventive Medicine and currently he is its Latin American Liaison. He has been Panel Reviewer for NIH, CDC, and NSF, Wellcome Foundation, and also served on the ACAIM Taskforce on International Health Security, Consultant for the United Nations Global Water Pathogens Project as well as for the United Kingdom and the Brazilian Academies of Sciences.
Wanwei Zhang view ≫
Affiliation: Department of Microbiology & Immunology, Columbia University, US
Interests: Bioinformatics; Non-coding RNA; B cell development; Genomic instability; Retro-transposable elements; Multi-omics analysis; Cancer
Biography: Dr. Wanwei Zhang focuses on the function of non-coding RNA in B cell development and the role of retro-transposable elements to genomic instability. He has published many research articles in scientific journals including Nature Genetics, Science Immunology and Molecular Cell. He also serves as reviewer for many journals including Bioinformatics, Frontiers in Genetics, Frontiers in Molecular Biosciences, Journal of Oncology, etc.
Xin Yang view ≫
Affiliation: Institute for Cancer Genetics, Herbert Irving Cancer Research Center, Columbia University, US
Interests: Cancer Genetics; Metabolism; Ferroptosis; Post-Translational Modification; Transcription
Biography: Dr. Xin Yang focuses on dissecting the role of cancer genetics factors, especially p53, in modulating cancer metabolism and ferroptosis. He has published more than 10 papers in scientific journals including Molecular Cell, Science Advances, Nature Communications, Cancer Research, EMBO Reports, Oncogene and Cell Death Disease. He also serves as reviewer in Frontiers in Oncology and Frontiers in Molecular Biosciences.
Yanan Ma view ≫
Affiliation: Memorial Sloan Kettering Cancer Center, US
Interests: Tumor microenvironment; Inflammation; Wound; Lipid; Ferroptosis; Transcription
Biography: Dr. Yanan Ma focuses on how the interaction between innate immune cells (neutrophil and macrophage) and tumor cells affects tumor microenvironment. She has published more than 20 papers in scientific journals including Science Advances, Cell Reports, Nature Cell Biology, PLoS One, Plant Biotechnology Journal, New Phytologist, Molecular Plant, Frontiers in Plant Science, Plant and Cell Physiology, Journal of Experimental Botany, Journal of Integrative Agriculture, Biotechnology and Applied Biochemistry, Plant Science. She also serves as reviewer for more than 11 journals including Journal of Integrative Medicine, Frontiers in Endocrinology, Oxidative Medicine and Cellular Longevity, Frontiers in Genetics, Frontiers in Pharmacology, BMC Cancer, BioMed Research International, Journal of Experimental Botany, Frontiers in Physiology, Frontiers in Molecular Bioscience, Plant Physiology and Biochemistry.
Yanqing Liu view ≫
Affiliation: Institute for Cancer Genetics, Herbert Irving Cancer Research Center, Columbia University, US
Interests: Non-coding RNA; Cancer; p53; Ferroptosis; Transcription
Biography: Dr. Yanqing Liu focuses on the roles of p53 in tumor development and functions of non-coding RNA in tumor. He has published more than 20 papers in scientific journals including Cell Death Differentiation, Seminars in Cancer Biology, Molecular Cancer, Protein Cell, and Journal of Molecular Cell Biology. He also serves as reviewer for more than 50 journals including Frontiers in series, BMC series, Molecular Oncology，Biomedicine & Pharmacotherapy, and Cell Communication and Signaling.
Zhe Wang view ≫
Affiliation: Institute for Cancer Genetics, Herbert Irving Cancer Research Center, Columbia University, US
Interests: Post-Translational Modifications (PTMs); Splicing protein; Ferroptosis; NRF2-KEAP1 system
Biography: Dr. Zhe Wang focuses on the potential role of PTMs in cancer-related proteins and ferroptosis regulation in response to metabolic stress, especially NRF2-KEAP1 system and splicing proteins. She has published around 10 papers in scientific journals including Molecular Cell, Cancer Research, EMBO Reports, Oncogene and The FASEB Journal. She also serves as reviewer in Oxidative Medicine and Cellular Longevity and Frontiers in Molecular Biosciences.
Zhenyi Su view ≫
Affiliation: Institute for Cancer Genetics, Herbert Irving Cancer Research Center, Columbia University, US
Interests: Cell death (ferroptosis, necroptosis, apoptosis, etc.); Cancer metastasis; Innate immune and cancer therapy
Biography: Dr. Zhenyi Su focuses on regulated cell death and cancer progression; reprogramming innate immunity for cancer therapy; gain-of-function of mutant p53 in cancer metastasis. He has published more than 20 papers in scientific journals including Nature Cell Biology, Cell Death Differentiation, Cell Death & Disease, Molecular Cancer, and EBioMedicine. He also serves as editor or reviewer for more than 20 journals including Frontiers in Pharmacology, Cells, and Journal of Cellular Immunology.
Qiao Lu view ≫
Affiliation: New York University Grossman School of Medicine, US
Interests: Antigen presentation; Cancer immunology; Immunotherapy
Biography: Dr. Qiao Lu focuses on the understanding of tumor immune evasion mechanisms and to develop the next-generation immunotherapies for treating cancer. He has published high-quality papers in scientific journals including Immunity, Nature communications, Nano letters, Cell research, and so on. He also serves as reviewer for Aging, BMC Immunology, Cancer Cell International, Journal of Medical Discovery, Frontiers in Genetics, Frontiers in Immunology, Heliyon, Open Medicine, Discover Oncology, and PLOS ONE.
Zhiwei Fang view ≫
Affiliation: Johns Hopkins University, US
Interest: Biomaterials; Immunoengineering; Drug delivery; Gene delivery; Hydrogels
Biography: Dr. Zhiwei Fang focuses on biomaterials, gene delivery, and drug delivery. He has authored or co-authored over 17 journal articles including Chemical Reviews, Journal of Nanobiotechnology, Biomaterials Science, and Frontiers in Immunology. He is also a reviewer for many scientific journals.
Affiliation: National Institute of Neurological Disorders and Stroke, NIH, US
Interests: B-/T-lymphocytes; Neuroinflammation; Cancer; Neurodegeneration; Membrane fusion and fission; Protein-protein interaction
Biography: Dr. Xin Wang focuses on the roles of B-/T-lymphocytes in tumor development and neurodegeneration. She has published 14 papers in scientific journals including Nature communications, Cancer Research, Cell Discovery, and Journal of Molecular Cell Biology. She also serves as a guest editor or reviewer for more than 9 journals including Nature Aging, Frontiers in series, Biomedicine & Pharmacotherapy, and Journal of Oncology.
Affiliation: Department of Pulmonary and Critical Care Medicine, Shanghai Geriatric Medical Center, Zhongshan Hospital, China
Interests: Lung cancer; Metastasis; Single nucleotide polymorphism; Circulating tumor cells; Genetics; Cancer risk; Platinum chemotherapy; Toxicity of chemotherapy; Prognosis
Biography: Dr. Junjie Wu focuses on the initiation, metastasis, and treatment of lung cancers. Until now, his high-level research projects have received fundings from National Natural Science Foundation of China and the Shanghai Postdoctoral Science Foundations. Also, he has published more than 50 papers in scientific journals, including Nature Genetics, Cancer Research and Clinical Cancer Research.
Affiliation: Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden
Interests: Receptor tyrosine kinase; Neuroblastoma; Anaplastic lymphoma kinase (ALK); ALK signaling; Targeted therapy
Biography: Dr. Jikui Guan focuses on the ALK signaling and ALK-based targeted therapy in neuroblastoma, a childhood cancer arising from the developing sympathetic nerve system. He has published more than 20 papers in scientific journals including Biology of Reproduction, BMC Developmental Biology, Molecular Reproduction and Development, elife, Disease Models & Mechanisms, Science Signaling, CSH Molecular Case Studies, PNAS, EMBO, Journal of Molecular Biology, Cancers and JCO Precision Oncology. He also serves as Review Editor or reviewer for more than 10 journals including Cancer Cell, Cancer Research, Cancer Letters, Cancers, Epigenetics, Biomolecules, International Journal of Molecular Sciences, International Journal of Biological Sciences, Biochemistry and Biophysics Reports, Plos ONE, Molecular Oncology, and Frontiers in Genetics.
Bo Li view >>
Affiliation: Sun Yat-sen Memorial Hospital, Sun Yat-sen University, China
Interests: Spinal cord injury; Osteoporosis; Nerve regeneration; Bone tumor
Biography: Dr. Bo Li specializes in clinical and basic research on spinal cord injury, bone tumors, and osteoporosis. He has published 34 studies in International Journal of Biological Sciences, J Drug Target, Neuropharmacology, and Neural Regen Res et.al. The H-index is 12 and the cumulative impact factor is 110. He has participated in two Chinese national projects and presided three provincial and municipal projects. He is the editor, guest editor and reviewer of Frontiers in Bioscience-Landmark, Frontiers in Oncology, Frontiers in Immunology and Frontiers in Neuroscience et al.
Yuanliang Yan view>>
Affiliation: Xiangya Hospital, Central South University, Hunan Province, China.
Interests: Cancer research; Molecular Biology; Cell death; Post-translational modification
Biography: Dr. Yan specializes in Pharmaceutics and Pharmacology. He received the systematic training in anti-cancer treatment at Xiangya Hosital, Central South University, China and Mayo Clinic, USA. Dr. Yan mainly focuses on the cancer therapy, with an ultimate goal of translating mechanistic insights gained for new therapeutic modalities. Yan published about 100 research papers in prestigious journals, including Mol Cancer (IF=27.401), Nucleic Acids Res (IF=16.971), J Hematol Oncol (IF=17.388), J Thorac Oncol (IF=13.357), Acta Pharm Sin B (IF=11.413), etc. Presently, he serves as the Associate Editor for BMC Pulm Med, Frontiers in Pharmacology, etc.
Jinhui Liu view>>
Affiliation: The First Affiliated Hospital of Nanjing Medical University
Interests: Tumor Immunology, Bioinformatics, Biomarker, Multi-omics Analysis, Tumor Microenvironment
Biography: His research activities mainly focus on the immune microenvironment markers of gynecological tumors with a multi group approach and has published over 60 research articles. He also served as associate editor of European Journal of Medical Research, member of editorial board of 10 SCI journals including Journal of Immunology Research, and guest editor of Frontiers in Genetics, Frontiers in Oncology, Oncology Research and Medicina.
Yinghuai Zhu view>>
Affiliation: HEC Pharma Co. Ltd., China
Interests: Antitumor drug; Biomaterials; Drug delivery; Functional materials; Catalysis
Biography: Professor Zhu focuses on antitumor drug, biomaterials, drug delivery, functional materials and catalysis. He has authored or co-authored over 85 journal articles and 12 book chapters, including Journal of the American Chemical Society, Angewandte Chemie - International Edition, Coordination chemistry reviews, etc. with more than 3300 citations with a h-index of 32. He is also a reviewer for many scientific journals.
Jie Mei view>>
Affiliation: Nanjing Medical University, China
Interests: Tumor Immune Microenvironment, Cancer Immunotherapy, Tumor Biomarker
Biography: Dr. Jie Mei specializes in clinical and translational research on tumor immune microenvironment. He has published more than 50 peer-reviewed articles in Molecular Cancer, JCI Insight, Clinical Immunology, and iScience et.al. The H-index is 17 and the cumulative impact factor is more than 260. He serves as Associate Editor of European Journal of Medical Research, Editorial Board Member of multiple SCIE-indexed journals, such as Journal of Immunology Research, BMC Cancer, and Journal of Oncology. He also serves as Review Editor or reviewer of more than 20 journals, such as Journal of Experimental & Clinical Cancer Research, Cellular & Molecular Biology Letters, and Frontiers in Immunology.
——————————————— Young Editors ——————————————
Renjun Gu view>>
Affiliation: Nanjing University of Chinese Medicine
Interests: Gastrointestinal cancer; Traditional Chinese Medicine; Pharmacology
Biography: Dr. Gu focuses on the diagnosis and treatment of gastrointestinal cancer and the treatment of Traditional Chinese Medicine. He has published papers in scientific journal including Cochrane Database of Systematic Reviews, Frontiers in Immunology, Oxid Med Cell Longev and etc. He is also Guest editor and reviewer for many scientific journals.
Xingliang Dai view>>
Affiliation: The First Affiliated Hospital of Anhui Medical University
Interests: Brain tumor; Nanomaterials; Bioprinting
Biography: Dr. Dai focuses on the diagnosis and treatment of brain tumors, especially glioma. He has published more than 80 papers in scientific journal including Biomaterials, Biofabrication, Acta Biomater, ACS Appl Mater Interfaces, Mil Med Res, Wiley Interdiscip Rev Nanomed Nanobiotechnol, Nanoscale, Cell Death Discov, International Journal of Bioprinting, etc. He led and contributed to numerous public funded research projects, including the National Natural Science Foundation project, the Natural Science Foundation of Anhui Province, etc. He was rated as "Excellent Young Physician of Neurosurgery in Anhui Province".
Shihao He view>>
Affiliation: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University
Interests: Neuroscience; Neurosurgery; Moyamoya disease; Stem cell; Organoid; Intracranial tumor; Signaling Pathway; Cognitive impairment; Vascular biology
Biography: Shihao He is currently a neurosurgeon at Beijing Tiantan Hospital, Capital Medical University. His clinical and preclinical research has focused on cognitive changes and disruption of brain networks in subgroups of patients with moyamoya disease and atherosclerosis. During his postgraduate training, he studied DNA methylation alterations in moyamoya disease, helped understand the involvement of DNA methylation in the pathogenesis of MMD, and proposed novel pathogenic genes as biomarkers. Shihao is currently engaged in the development of moyamoya disease organoid models to explore the molecular mechanisms of pathological angiogenesis and novel therapeutic strategies. Shihao joined the lab of Gary Steinberg, Stanford School of Medicine, in 2022 to conduct visiting research to better understand the pathogenesis of moyamoya disease. He is a member of Science AAAS Students and Postdocs Community. He has published 16 papers in scientific journals, including Journal of Cerebral Blood Flow & Metabolism; Translational Stroke Research; Scientific Reports; BMC Neurology.
Yixin Wang view>>
Affiliation: School of biomedical science, Chinese University of Hong Kong
Interests: RNA Therapy; RNA vaccine; COVID-19; Virology; Immunology
Biography: Dr. Yixin Wang is currently a Postdoc at the school of biomedical science, Chinese University of Hong Kong. Dr. Wang has interests in the combined field of RNA therapy, RNA vaccines, COVID-19, and virology are individuals, and fascinated by the potential of RNA molecules to revolutionize disease treatment and prevention. She investigated the virus entry mechanisms of MERS-CoV, viral-host interaction between coronavirus and the host. Since 2019, she has published series of papers related to SARS-CoV-2, successfully reveled the mechanisms of high contagious and immune suppressive of SARS-CoV-2. Related paper was published on the Clinical Infectious Disease and has more than 3000 citations till now.
Affiliation: Department of Nuclear Medicine, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China
Interests: Tumor Imaging and Detection, MRI/CT, Artificial Intelligence; Radiomics.
Biography: Prof. Hu has been engaged in clinical, teaching, and research work in tumor imaging for a long time, and often participate in the Multidisciplinary team of Southwest Hospital as an imaging expert. He has published 26 SCI articles with a cumulative impact factor of 100 or more and an H-index of 14. He is also on the editorial board of Brain Science, Journal of Translational Internal Medicine, etc., a frequent guest editor for Frontiers in Neurology, Frontiers in Neuroscience, etc., and a reviewer for Frontiers in Immunology, Liver International, etc.
Affiliation: Medical Big Data Research Center, Chinese PLA General Hospital; National Engineering Research Center for Medical Big Data Application Technology
Interests: bioinformation and clinical research, including precision medicine, prognostic model and artificial intelligence applications to public health and data analysis
Biography: Dr. Yin has published about 60 research papers, of which 36 articles with first or corresponding author. The main part-time jobs include specialized committee member of tumor etiology and the specialized committee on tumor markers of the Chinese anti-cancer association. Currently, he serves as an advisory board member of Heliyon, and editor for several journals. He is the reviewer for many reputed journals.
Affiliation: Department of Sports Medicine, Huashan Hospital, Fudan University
Interests: Cancer microenvironment, Stem cell-based therapy and Biomaterials.
Biography: Dr. Zhiwen Luo served as editorial board/young editorial board member of 21 academic journals and reviewer of more than 30 SCI journals, such as Journal of Advanced Research, Translational Research, Journal of Nanobiotechnology, and so on; published over 30 papers in SCI-indexed journals (27 as (co-)first /corresponding author, total IF>180, 3 articles with IF>15：Small(Cover story), Bioactive Materials, Biomaterials Research, 1 article with IF>10: IJBS); Vice Chairman of the 35th graduate student union of Huashan hospital, Fudan university. He was invited by the official Dingxiang DXY BBS to become a center expert, published nearly 40 popular science articles with over 200,000 visits.
Roberta Cardim Lessa Teixeira view>>
Affiliation: Auckland University of Technology, New Zealand
Interests: Oral medicine; Oral and Head and Neck Cancer; Side effects; Cancer care; Inflammation; Molecular biology
Biography: Ph.D. Roberta works in Auckland University of Technology. She published articles in such journals as Biomedicines, Photodiagnosis and Photodynamic Therapy, BMC Cancerand Cancer Research.
Affiliation: Department of Cancer Biology, College of Medicine, University of Cincinnati, VONTZ Building, 3125 Eden Ave, Cincinnati OH 45267-0521, United States
Interests: Developing brain cancer; Glia in oncology; Immunology of brain cancer; Glial neurobiology; Neuroinflammation
Biography: Dr. Aarti Nagayach has published papers in scientific journal including Journal in Chemical Neuroanatomy, PLoS One, Journal of Neuroscience Methods, Brain Research and etc. He is also Guest editor and reviewer for many scientific journals including Journal of Clinical Medicine，BioMedicine，Journal of Clinical Medicine and so on. She has attended more than 10 conferences and presentations.